...
首页> 外文期刊>Journal of chemical information and modeling >Computational Method To Identify Druggable Binding Sites That Target Protein-Protein Interactions
【24h】

Computational Method To Identify Druggable Binding Sites That Target Protein-Protein Interactions

机译:识别靶向蛋白质-蛋白质相互作用的药物结合位点的计算方法

获取原文
获取原文并翻译 | 示例

摘要

Protein-protein interactions are implicated in the pathogenesis of many diseases and are therefore attractive but challenging targets for drug design. One of the challenges in development is the identification of potential druggable binding sites in protein interacting interfaces. Identification of interface surfaces can greatly aid rational drug design of small molecules inhibiting protein-protein interactions. In this work, starting from the structure of a free monomer, we have developed a ligand docking based method, called "FindBindSite" (FBS), to locate protein-protein interacting interface regions and potential druggable sites in this interface. FindBindSite utilizes the results from docking a small and diverse library of small molecules to the entire protein structure. By clustering regions with the highest docked ligand density from FBS, we have shown that these high ligand density regions strongly correlate with the known protein-protein interacting surfaces. We have further predicted potential druggable binding sites on the protein surface using FBS, with druggability being defined as the site with high density of ligands docked. FBS shows a hit rate of 71% with high confidence and 93% with lower confidence for the 41 proteins used for predicting druggable binding sites on the protein-protein interface. Mining the regions of lower ligand density that are contiguous with the high scoring high ligand density regions from FBS, we were able to map 70% of the protein-protein interacting surface in 24 out of 41 structures tested. We also observed that FBS has limited sensitivity to the size and nature of the small molecule library used for docking. The experimentally determined hotspot residues for each protein-protein complex cluster near the best scoring druggable binding sites identified by FBS. These results validate the ability of our technique to identify druggable sites within protein-protein interface regions that have the maximal possibility of interface disruption.
机译:蛋白质-蛋白质相互作用与许多疾病的发病机制有关,因此是药物设计的有吸引力但具有挑战性的目标。开发中的挑战之一是在蛋白质相互作用界面中潜在的可药物结合位点的鉴定。界面表面的鉴定可以极大地帮助小分子药物合理设计,从而抑制蛋白质-蛋白质相互作用。在这项工作中,我们从游离单体的结构开始,开发了一种基于配体对接的方法,称为“ FindBindSite”(FBS),用于在该界面中定位蛋白质-蛋白质相互作用的界面区域和潜在的可药用位点。 FindBindSite利用将小型多样的小分子文库与整个蛋白质结构对接的结果。通过聚类来自FBS的最高对接配体密度的区域,我们显示出这些高配体密度区域与已知的蛋白质-蛋白质相互作用表面密切相关。我们使用FBS进一步预测了蛋白质表面上潜在的可药物结合位点,可药物化定义为高密度配体对接的位点。对于用于预测蛋白质-蛋白质界面上可药用结合位点的41种蛋白质,FBS的命中率为71%(高置信度)和93%(较低置信度)。从FBS挖掘与高得分高配体密度区域相邻的较低配体密度区域,我们能够在41个测试结构中的24个中绘制出70%的蛋白质-蛋白质相互作用表面。我们还观察到FBS对用于对接的小分子文库的大小和性质的敏感性有限。实验确定的每个蛋白质-蛋白质复合物簇的热点残基都靠近FBS鉴定的得分最高的可药物结合位点。这些结果证实了我们的技术能够识别蛋白质-蛋白质界面区域内具有最大界面破坏可能性的药物位点的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号